REGN returns by year
Regeneron Pharmaceuticals Inc. has returned +11.9% annually (CAGR) since 1992. Calendar-year, monthly and weekly total returns for Regeneron Pharmaceuticals Inc. (REGN) below, through July 2, 2026 — the most recent year is year-to-date.
Regeneron Pharmaceuticals Inc. returns by year (1992–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return).
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $771.87 | $654.27 | +0.2% | -15.0% | |
| 2025 | $712.33 | $771.87 | +0.6% | +9.0% | |
| 2024 | $878.29 | $712.33 | +0.0% | -18.9% | |
| 2023 | $721.49 | $878.29 | +0.0% | +21.7% | |
| 2022 | $631.52 | $721.49 | +0.0% | +14.2% | |
| 2021 | $483.11 | $631.52 | +0.0% | +30.7% | |
| 2020 | $375.48 | $483.11 | +0.0% | +28.7% | |
| 2019 | $373.50 | $375.48 | +0.0% | +0.5% | |
| 2018 | $375.96 | $373.50 | +0.0% | -0.7% | |
| 2017 | $367.09 | $375.96 | +0.0% | +2.4% | |
| 2016 | $542.87 | $367.09 | +0.0% | -32.4% | |
| 2015 | $410.25 | $542.87 | +0.0% | +32.3% |
Total return by period
Methodology#
Returns are total returns (dividends reinvested), computed from REGN's split- and dividend-adjusted closes. The bar chart switches between annual and monthly periods. Annualized return is the compound annual growth rate over the full period. The current year is year-to-date. See also the periodic table of returns. Past performance does not predict future returns; not investment advice.
See also: S&P 500 · Nasdaq-100 · Dow Jones · Russell 2000 · US Bond Market · Gold · Silver · Bitcoin · Ethereum
FAQ
- What is Regeneron Pharmaceuticals Inc.'s average annual return?
- Since 1992, Regeneron Pharmaceuticals Inc. (REGN) has returned about 11.9% a year (the compound annual growth rate) and an average calendar-year return of 28.8%.
- What were Regeneron Pharmaceuticals Inc.'s best and worst years?
- Over 1992–2026, the best year was 1995 (+325.0%) and the worst was 1994 (-80.6%).
- How often is Regeneron Pharmaceuticals Inc. up in a year?
- 22 of the 34 full years since 1992 were positive — about 65% of the time.